New Delhi: Cancer patients facing prohibitive treatment costs in India can hope for relief: the nation's top drugmakers have ...

A global elderly and aging population has significant impacts, not only in terms of individual health risk but in terms of ...

As an enterprise engaged in the development, manufacturing and commercialization of specialty plasma-derived therapeutics, ...

ERS Summit emphasizes on advancing respiratory health in India: Shardul Nautiyal, Mumbai Friday, February 28, 2025, 08:00 Hrs [IST] The European Respiratory Summit in Mumbai marke ...

Non-communicable diseases pose a significant global health challenge, requiring preventive measures and lifestyle changes for ...

Q4 2024 Earnings Call Transcript February 27, 2025 Ligand Pharmaceuticals Incorporated misses on earnings expectations.

With over half the cells in the human body being bacterial rather than human, and over 99% of the genes in the human body ...

NHS England will remove 32 QOF indicators and invest their funding into global sum, childhood vaccinations and cardiovascular prevention.

Astrana Health, Inc. ( NASDAQ: ASTH) Q4 2024 Earnings Conference Call February 27, 2025 5:30 PM ET Brandon Sim - President & CEO Chan Basho - Chief Operating & Financial Officer ...

Verona Pharma has blockbuster hopes for its recently approved drug for chronic obstructive pulmonary disorder (COPD), and preliminary sales figures for the drug suggest it is heading in the right ...

UK-based Verona Pharma has scored a key win in a phase 3 trial of its chronic obstructive pulmonary disease (COPD) drug ensifentrine, setting up regulatory filings in the first half of next year.